North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 179 Sep 25 – Oct 24, 2026
- Disclosed funding
- $20.7B 156 disclosed amounts
- Median round
- $30M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| T TownCompany profile Town is a personal AI assistant that works across email, calendars, documents and messaging to handle tasks in a user’s connected tools. Town is a personal AI assistant that works across email, calendars, documents and messaging to handle tasks in a user’s connected tools. | $108M | Series B | AI | United States | Investors | |
| T TolanCompany profile Tolan develops a voice-first AI companion that remembers conversations and helps people organize everyday life. Tolan develops a voice-first AI companion that remembers conversations and helps people organize everyday life. | $30M | Undisclosed | AI | United States | Investors | |
| T TenstorrentCompany profile Tenstorrent builds AI processors, computing systems and licensable chip designs for developers, enterprises and infrastructure operators. Tenstorrent builds AI processors, computing systems and licensable chip designs for developers, enterprises and infrastructure operators. | $1.5B | Series ESeries C+ | AI | United States | Investors | |
| R RapidCanvasCompany profile RapidCanvas builds and operates custom enterprise AI applications using a software platform and field engineering teams. RapidCanvas builds and operates custom enterprise AI applications using a software platform and field engineering teams. | $29M | Series B | AI | United States | Investors | |
| EB Estuary BiotherapeuticsCompany profile Estuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease. Estuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease. | $93M | Series A | Biotech | United States | Investors | |
| R RSYNQCompany profile RSYNQ develops middleware that connects AI instructions with robots, sensors and other physical systems. RSYNQ develops middleware that connects AI instructions with robots, sensors and other physical systems. | $2M | Strategic investmentUndisclosed | Robotics | United States | Investors | |
| N North.cloudCompany profile Cloud spending software that helps engineering and finance teams allocate costs and automate infrastructure savings. Cloud spending software that helps engineering and finance teams allocate costs and automate infrastructure savings. | $60M | Series B | Enterprise software | United States | Investors | |
| O OpsinCompany profile Opsin helps enterprises discover AI agents, assess their permissions and contain risky behaviour. Opsin helps enterprises discover AI agents, assess their permissions and contain risky behaviour. | $21M | Funding roundUndisclosed | Cybersecurity | United States | Investors | |
| H HomaCompany profile Homa combines an AI homebuying platform with licensed brokerage services in the United States. Homa combines an AI homebuying platform with licensed brokerage services in the United States. | $5M | Seed | Proptech | United States | Investors | |
| OH Otter HealthCompany profile Clinical intelligence software helping healthcare payers and providers assess care decisions against evidence and guidelines. Clinical intelligence software helping healthcare payers and providers assess care decisions against evidence and guidelines. | $8M | Seed | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Sep 25, 2026
- 1Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
19rounds9led - 2Y Combinator (YC)
Tractian, Blacksmith, Greptile
13rounds0led - 3Khosla Ventures
Arda Industries, Tolan
10rounds3led - 4General Catalyst
Tractian, Different, Baba
9rounds3led - 5Sequoia Capital
Warhound, Whop, Blacksmith
9rounds4led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.